Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 2,330 | 2,069 | 6,119 | 14,519 | 7,372 |
| Gross Profit | 2,330 | 2,069 | 6,119 | 14,519 | 7,372 |
| Operating Expenses | 37,979 | 33,331 | 32,372 | 30,777 | 47,029 |
| Operating Income | -35,649 | -31,262 | -26,253 | -16,258 | -39,657 |
| Interest Expense | -1,931 | -2,057 | 886 | 4 | -780 |
| Other Income | -68 | -44 | 2,085 | 1,024 | 154 |
| Pre-tax Income | -33,786 | -29,249 | -25,054 | -15,238 | -38,723 |
| Net Income Continuous | -33,786 | -29,249 | -25,054 | -15,238 | -38,723 |
| Net Income | $-33,786 | $-29,249 | $-25,054 | $-15,238 | $-38,723 |
| EPS Basic Total Ops | -0.69 | -0.60 | -0.52 | -0.32 | -0.82 |
| EPS Basic Continuous Ops | -0.69 | -0.60 | -0.52 | -0.32 | -0.82 |
| EPS Diluted Total Ops | -0.69 | -0.60 | -0.52 | -0.32 | -0.82 |
| EPS Diluted Continuous Ops | -0.69 | -0.60 | -0.52 | -0.32 | -0.82 |
| EBITDA(a) | $-34,956 | $-30,634 | $-25,373 | $-15,419 | $-38,873 |